OR-AIRSHIP
1.6.2022 12:02:12 CEST | Business Wire | Press release
Mobile app experience company Airship today announced that it has acquired Gummicube , the original App Store Optimization (ASO) innovator and the world’s #1 provider in helping more top 10 apps across categories succeed than any other company. By linking Gummicube's ASO technology and expertise with Airship's App Experience Platform (AXP), brands can now optimize value across the entire mobile app lifecycle, driving greater organic growth, ROAS, retention, loyalty and monetization.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220601005529/en/
The acquisition combines the leading ASO platform with the leading mobile app experience platform to offer brands a single set of enterprise solutions that together offer app store optimization, customer journey orchestration, no-code native app experiences and app UX experimentation. Both Airship and Gummicube customers will quickly benefit from access to new technology and expanded expertise to bookend growth and retention by more efficiently and effectively addressing both sides of the mobile app value chain — attracting and growing more valuable app customers, then retaining and monetizing them.
Gummicube nearly doubled its revenue year-over-year, with nearly three-quarters of total revenue coming from enterprise brands, and plans to nearly double its staff in 2022 to support continued growth. All 80 Gummicube employees have joined Airship with co-founders Dave Bell and Anh Nguyen becoming VPs and co-general managers of the Gummicube division at Airship. Airship will continue to innovate and invest in Gummicube’s solutions, while empowering customers with richer cross-platform data to better inform each step of the mobile app journey, from the experiences new app customers receive, to the insights that drive the next wave of organic audience growth.
“Driving consumers to download an app is a critical first step, but keeping them engaged and maximizing value for everyone involved requires leveraging data to demonstrate customer respect and relevance with experiences that reward them for their loyalty,” said Brett Caine, CEO and president, Airship. “Together, Gummicube and Airship enable marketers, product owners and developers to optimize their entire mobile app experience — from the point of discovery to loyalty. This industry-first combination will drive greater app success for brands, and unlock huge value for our business.”
“Gummicube and Airship are both 100% dedicated to helping mobile apps succeed. Before today, brands had to find their own answers to the two most fundamental questions: one, how do I attract and grow more quality users; and two, how do I retain them and grow value for everyone involved,” said Dave Bell, CEO and co-founder, Gummicube. “Now, our combination will drive more measurable value for customers than anyone else. This has never been done before!”
Splitcube, Gummicube’s A/B testing platform, enables developers, marketers and brands to test every single one of their store listing assets to continually optimize conversion rates in the app stores. Gummicube’s DATACUBE aggregates billions of data points from the App Store and Google Play Store to visualize search and behavioral trends. DATACUBE helps app marketers understand how the app stores merchandise their apps and those of their competitors, to more quickly grow app audiences and market share by optimizing app visibility. These SaaS technologies are combined with the most experienced ASO team in the world, who can work hand in hand with clients to manage processes and measure success.
Peak Technology Partners served as the exclusive sell-side advisor in this transaction.
Airship is dedicating the month of June to #MAXMonth where there will be a wealth of content, events and resources to help brands master mobile app experiences and unlock more value by optimizing the full app lifecycle. Learn more here: https://www.airship.com/max-month/ .
Airship is a Leader in “The Forrester Wave™: Mobile Engagement Automation, Q3 2020 ,” receiving the highest score in the Strategy category and the second highest score in the Current Offering category.
About Gummicube
Gummicube pioneered App Store Optimization for mobile apps in 2010, and today partners with app developers and CMOs to optimize mobile app marketing for the App Store and Google Play Store. Thousands of apps have leveraged Gummicube’s technology and expert services to continuously improve app visibility and store conversion rates to acquire more quality users and build better apps.
Gummicube is an Airship company. For more information on Gummicube's services, or to receive a live demo of DATACUBE or Splitcube, please visit http://www.gummicube.com/ .
About Airship
No one knows more, does more, or cares more when it comes to helping brands master mobile app experiences than Airship.
From the beginning of apps, Airship powered the first commercial messages and then expanded its data-led approach to all re-engagement channels (mobile wallet, SMS, email), app UX experimentation and feature release management. Now, with the Airship App Experience Platform (AXP), business users can create and adapt native app experiences on their own — with no ongoing developer support or app update required.
Having powered trillions of mobile app interactions for thousands of global brands, Airship’s technology and deep industry expertise have enabled apps to become the digital center of customer experience, brand loyalty and monetization.
For more information, visit www.airship.com , read our blog or follow us on Twitter , LinkedIn and Facebook .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220601005529/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting tilføjer samarbejdsfirmaet TechSparq25.10.2026 06:09:00 CET | Pressemeddelelse
Andersen Consulting udvider sine kompetencer inden for teknologi og forretningstransformation gennem en samarbejdsaftale med TechSparq, en amerikansk virksomhed, der kombinerer strategi, commerce engineering og ai med praktisk implementering. TechSparq er et digitalt konsulenthus, der tilbyder strategi- og rådgivningstjenester, commerce engineering samt tjenester inden for ai og agentbaseret handel til virksomheder inden for detailhandel og forbrugsgoder, luksus og mode samt e-handel og direkte salg til forbrugere. Virksomheden har hovedkontor i Oregon og kombinerer strategisk planlægning med praktisk implementering for at hjælpe kunderne med at udvikle deres digitale initiativer, kundeoplevelse og driftsmodeller. "Vi etablerede vores virksomhed for at bygge bro mellem dem, der udvikler strategien, og dem, der har ansvaret for at føre den ud i livet," udtalte Dedrick Boyd, stifter af og administrerende direktør for TechSparq. "Vores samarbejde med Andersen Consulting giver os mulighed
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release
Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom